The Role of Neutrophils and NETosis in Diseases: The Implications for Therapy

Abstract

Neutrophils are the most abundant innate immune cells and are pivotal first responders in host defense, playing an important role in maintaining body homeostasis and regulating pathological conditions. Growing evidence indicates that neutrophils exhibit functional heterogeneity and participate in immune regulation through processes such as neutrophil extracellular trap formation (NETosis). These findings have expanded the traditional view of neutrophils as short-lived effector cells. Nevertheless, how distinct neutrophil states are temporally coordinated during disease development, and how this coordination may be therapeutically exploited, remains insufficiently understood. In this review, we provide a comprehensive overview of neutrophil biology, focusing on functional heterogeneity, NETosis, and their roles in infectious diseases, autoimmune disorders, and cancers. We further discuss emerging therapeutic strategies targeting neutrophils, as well as advanced technologies that have enabled high-resolution characterization of neutrophil states and functions. Building on the evidence above, the concept of “neutrophil immune clock” is proposed to describe the temporal changes in neutrophil-mediated immune responses. A time-resolved perspective on neutrophil responses may offer new insights into disease progression and support the development of neutrophil-targeted strategies for disease prevention and therapy.

Keywords

heterogeneity / immune clock / multiomics / NETosis / neutrophils

References

[1] D. Cerezo-Wallis, A. Rubio-Ponce, M. Richter, et al., “Architecture of the Neutrophil Compartment,” Nature 649 (2026): 1003–1012.

[2] N. Borregaard, “Neutrophils, From Marrow to Microbes,” Immunity 33 (2010): 657–670.

[3] E. Kolaczkowska and K. Paul, “Neutrophil Recruitment and Function in Health and Inflammation,” Nature Reviews Immunology 13 (2013): 159–175.

[4] C. Silvestre-Roig, Z. G. Fridlender, M. Glogauer, and P. Scapini, “Neutrophil Diversity in Health and Disease,” Trends in Immunology 40 (2019): 565–583.

[5] S. Liu, W. Wu, and Y. Du, “The Evolution and Heterogeneity of Neutrophils in Cancers: Origins, Subsets, Functions, Orchestrations and Clinical Applications,” Molecular Cancer 22 (2023): 148.

[6] A. Hidalgo, E. R. Chilvers, and C. Summers, “The Neutrophil Life Cycle,” Trends in Immunology 40 (2019): 584–597.

[7] K. Ley, C. Laudanna, M. I. Cybulsky, and S. Nourshargh, “Getting to the Site of Inflammation: the Leukocyte Adhesion Cascade Updated,” Nature Reviews Immunology 7 (2007): 678–689.

[8] V. Brinkmann, U. Reichard, C. Goosmann, et al., “Neutrophil Extracellular Traps Kill Bacteria,” Science 303 (2004): 1532–1535.

[9] V. Papayannopoulos, “Neutrophil Extracellular Traps in Immunity and Disease,” Nature Reviews Immunology 18 (2018): 134–147.

[10] T. A. Fuchs, U. Abed, C. Goosmann, et al., “Novel Cell Death Program Leads to Neutrophil Extracellular Traps,” Journal of Cell Biology 176 (2007): 231–241.

[11] K. Ella, R. Csépányi-Kömi, and K. Káldi, “Circadian Regulation of Human Peripheral Neutrophils,” Brain, Behavior, and Immunity 57 (2016): 209–221.

[12] H. P. Sennels, H. L. Jørgensen, A. L. Hansen, et al., “Diurnal Variation of Hematology Parameters in Healthy Young Males: the Bispebjerg Study of Diurnal Variations,” Scandinavian Journal of Clinical and Laboratory Investigation 71(2011): 532–541.

[13] M. Casanova-Acebes, C. Pitaval, L. A. Weiss, et al., “Rhythmic Modulation of the Hematopoietic Niche Through Neutrophil Clearance,” Cell 153(2013): 1025–1035.

[14] C. Scheiermann, Y. Kunisaki, D. Lucas, et al., “Adrenergic Nerves Govern Circadian Leukocyte Recruitment to Tissues,” Immunity 37 (2012): 290–301.

[15] A. J. Templeton, M. G. McNamara, B. Šeruga, et al., “Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: a Systematic Review and Meta-analysis,” JNCI: Journal of the National Cancer Institute 106 (2014):dju124.

[16] A. Szredzka, A. Chwastowicz, J. Pergoł, et al., “Circadian Clocks and Adaptive Immune Function: From Mechanisms to Therapeutic Applications,” Frontiers in Immunology 16 (2025):1697854.

[17] Y. Otobe, N. Deki-Arima, S. Xinyan, et al., “A Mouse Circadian Proteome Atlas,” Molecular Cell 86 (2026): 393–406.e3.

[18] L. G. Ng, R. Ostuni, and A. Hidalgo, “Heterogeneity of Neutrophils,” Nature Reviews Immunology 19 (2019): 255–265.

[19] P. Scapini, O. Marini, and C. Tecchio, “Human Neutrophils in the Saga of Cellular Heterogeneity: Insights and Open Questions,” Immunological Reviews 273 (2016): 48–60.

[20] X. Xie, Q. Shi, and P. Wu, “Single-Cell Transcriptome Profiling Reveals Neutrophil Heterogeneity in Homeostasis and Infection,” Nature Immunology 21 (2020): 1119–1133.

[21] C. Radermecker, C. Sabatel, and C. Vanwinge, “Locally Instructed CXCR4^hi Neutrophils Trigger Environment-Driven Allergic Asthma Through the Release of Neutrophil Extracellular Traps,” Nature Immunology 20 (2019): 1444–1455.

[22] K. De Filippo and S. M. Rankin, “CXCR4, The Master Regulator of Neutrophil Trafficking in Homeostasis and Disease,” European Journal of Clinical Investigation 2018 ( 2018):e12949.

[23] C. Silvestre-Roig, A. Hidalgo, and O. Soehnlein, “Neutrophil Heterogeneity: Implications for Homeostasis and Pathogenesis,” Blood 127 (2016): 2173–2181.

[24] K. J. Eash, A. M. Greenbaum, and P. K. Gopalan, “CXCR2 and CXCR4 Antagonistically Regulate Neutrophil Trafficking From Murine Bone Marrow,” Journal of Clinical Investigation 120 (2010): 2423–2431.

[25] L. M. Zhu, D. Zeng, and X. C. Lei, “KLF2 Regulates Neutrophil Migration by Modulating CXCR1 and CXCR2 in Asthma,” Biochim Biophys Acta Mol Basis Dis 1866 (2020):165920.

[26] J. Hu, Q. Ji, and F. Chen, “CXCR2 is Essential for Radiation-Induced Intestinal Injury by Initiating Neutrophil Infiltration,” Journal of Immunology Research 2022 (2022):7966089.

[27] S. Shao, N. A. Delk, and C. N. Jones, “A Microphysiological System Reveals Neutrophil Contact-Dependent Attenuation of Pancreatic Tumor Progression by CXCR2 Inhibition-Based Immunotherapy,” Scientific Reports 14 (2024):14142.

[28] H. Q. Dinh, T. Eggert, and M. A. Meyer, “Coexpression of CD71 and CD117 Identifies an Early Unipotent Neutrophil Progenitor Population in Human Bone Marrow,” Immunity 53 (2020): 319–334.

[29] S. M. Lawrence, R. Corriden, and V. Nizet, “The Ontogeny of a Neutrophil: Mechanisms of Granulopoiesis and Homeostasis.” Microbiology and Molecular Biology Reviews 82 (2018): e00057–117.

[30] M. Kelm, S. Lehoux, and V. Azcutia, “Regulation of Neutrophil Function by Selective Targeting of Glycan Epitopes Expressed on the Integrin CD11b/CD18,” Faseb Journal 34 (2020): 2326–2343.

[31] U. J. Sachs, C. L. Andrei-Selmer, and A. Maniar, “The Neutrophil-Specific Antigen CD177 Is a Counter-Receptor for Platelet Endothelial Cell Adhesion Molecule-1 (CD31),” Journal of Biological Chemistry 282 (2007): 23603–23612.

[32] F. W. Verheugt, A. E. von dem Borne, and J. C. van Noord-Bokhorst, “Serological, Immunochemical and Immuoncytological Properties of Granulocyte Antibodies,” Vox Sanguinis 35 (1978): 294–303.

[33] G. Zhou, L. Yu, and L. Fang, “CD177⁺ Neutrophils as Functionally Activated Neutrophils Negatively Regulate IBD,” Gut 67 (2018): 1052–1063.

[34] R. Zhang, L. Su, and M. Fu, “CD177⁺ Cells Produce Neutrophil Extracellular Traps That Promote Biliary Atresia,” Journal of Hepatology 77 (2022): 1299–1310.

[35] M. Bai, R. Grieshaber-Bouyer, and J. Wang, “CD177 Modulates Human Neutrophil Migration Through Activation-Mediated Integrin and Chemoreceptor Regulation,” Blood 130 (2017): 2092–2100.

[36] N. S. Hackert, F. A. Radtke, T. Exner, et al., “Human and Mouse Neutrophils Share Core Transcriptional Programs in both Homeostatic and Inflamed Contexts,” Nature Communications 14 (2023): 8133.

[37] S. Ling and J. W. Xu, “Phenotypes and Functions of ‘Aged’ Neutrophils in Cardiovascular Diseases,” Biomedicine & Pharmacotherapy 179 (2024):117324.

[38] J. Gibbs, L. Ince, L. Matthews, et al., “An Epithelial Circadian Clock Controls Pulmonary Inflammation and Glucocorticoid Action,” Nature Medicine 20 (2014): 919–926.

[39] D. Zhang, G. Chen, D. Manwani, et al., “Neutrophil Ageing Is Regulated by the Microbiome,” Nature 525 (2015): 528–532.

[40] A. Aroca-Crevillén, J. M. Adrover, and A. Hidalgo, “Circadian Features of Neutrophil Biology,” Frontiers in Immunology 11 (2020): 576.

[41] Y. Aratani, “Myeloperoxidase: Its Role for Host Defense, Inflammation, and Neutrophil Function,” Archives of Biochemistry and Biophysics 640 (2018): 47–52.

[42] K. Amunugama, G. R. Kolar, and D. A. Ford, “Neutrophil Myeloperoxidase Derived Chlorolipid Production During Bacteria Exposure”. Frontiers in Immunology 12 (2021):701227.

[43] M. M. Islam and N. Takeyama, “Role of Neutrophil Extracellular Traps in Health and Disease Pathophysiology: Recent Insights and Advances,” International Journal of Molecular Sciences 24 (2023):15805.

[44] K. Kessenbrock, M. Krumbholz, and U. Schönermarck, “Netting Neutrophils in Autoimmune Small-Vessel Vasculitis,” Nature Medicine 15 (2009): 623–625.

[45] Y. Peng, X. Wu, and S. Zhang, “The Potential Roles of Type I Interferon Activated Neutrophils and Neutrophil Extracellular Traps (NETs) in the Pathogenesis of Primary Sjögren's Syndrome,” Arthritis Research & Therapy 24 (2022): 170.

[46] I. V. Gorudko, D. V. Grigorieva, and A. V. Sokolov, “Neutrophil Activation in Response to Monomeric Myeloperoxidase,” Biochemistry and Cell Biology 96 (2018): 592–601.

[47] M. J. Schloss, M. Horckmans, K. Nitz, et al., “The Time-of-Day of Myocardial Infarction Onset Affects Healing Through Oscillations in Cardiac Neutrophil Recruitment,” EMBO Molecular Medicine 8 (2016): 937–948.

[48] C. Scheiermann, Y. Kunisaki, and P. S. Frenette, “Circadian Control of the Immune System.” Nature Reviews Immunology 13 (2013): 190–198.

[49] R. Pick, W. He, C. S. Chen, and C. Scheiermann, “Time-of-Day-Dependent Trafficking and Function of Leukocyte Subsets,” Trends in Immunology 40 (2019): 524–537.

[50] W. He, S. Holtkamp, S. M. Hergenhan, et al., “Circadian Expression of Migratory Factors Establishes Lineage-Specific Signatures That Guide the Homing of Leukocyte Subsets to Tissues,” Immunity 49 (2018): 1175–1190.e7.

[51] J. M. Adrover, A. Aroca-Crevillén, G. Crainiciuc, et al., “Programmed ‘Disarming’ of the Neutrophil Proteome Reduces the Magnitude of Inflammation,” Nature Immunology 21 (2020): 135–144.

[52] J. M. Adrover, C. Del Fresno, G. Crainiciuc, et al., “A Neutrophil Timer Coordinates Immune Defense and Vascular Protection,” Immunity 51 (2019): 966–967.

[53] A. Aroca-Crevillén, S. Martín-Salamanca, L. S. Torres, et al., “A Circadian Checkpoint Relocates Neutrophils to Minimize Injury,” Journal of Experimental Medicine 223 (2026):e20250240.

[54] L. Y. Du, P. Keerthisinghe, L. Rolland, et al., “A Light-regulated Circadian Timer Optimizes Neutrophil Bactericidal Activity to Boost Daytime Immunity,” Science Immunology 10 (2025):eadn3080.

[55] G. Trinchieri, “Biology of Natural Killer Cells,” Advances in Immunology 47 (1989): 187–376.

[56] R. M. Steinman, “The Dendritic Cell System and Its Role in Immunogenicity,” Annual Review of Immunology 9 (1991): 271–296.

[57] L. S. C. Lok and M. R. Clatworthy, “Neutrophils in Secondary Lymphoid Organs,” Immunology 164 (2021): 677–688.

[58] M. Giese, N. Turiello, and N. Molenda, “Exogenous Cathepsin G Upregulates Cell Surface MHC Class I Molecules on Immune and Glioblastoma Cells,” Oncotarget 7 (2016): 74602–74611.

[59] N. Garbi, P. Tan, and A. D. Diehl, “Impaired Immune Responses and Altered Peptide Repertoire in Tapasin-Deficient Mice,” Nature Immunology 1 (2000): 234–238.

[60] S. J. Cleary, N. Kwaan, and J. J. Tian, “Complement Activation on Endothelium Initiates Antibody-Mediated Acute Lung Injury,” Journal of Clinical Investigation 130 (2020): 5909–5923.

[61] Q. Zhao, D. P. Chen, and H. D. Chen, “NK-Cell-Elicited Gasdermin-D-Dependent Hepatocyte Pyroptosis Induces Neutrophil Extracellular Traps That Facilitate HBV-Related Acute-on-Chronic Liver Failure,” Hepatology 81 (2025): 917–931.

[62] P. Forrer, D. Palianina, and C. Stühler, “Unveiling Signaling Pathways Inducing MHC Class II Expression in Neutrophils,” Frontiers in Immunology 15 (2024):1444558.

[63] A. Takashima and Y. Yao, “Neutrophil Plasticity: Acquisition of Phenotype and Functionality of Antigen-Presenting Cell,” J Leukoc Biol 98 (2015): 489–496.

[64] K. E. Bernstein, Z. Khan, and J. F. Giani, “Angiotensin-Converting Enzyme in Innate and Adaptive Immunity,” Nature Reviews Nephrology 14 (2018): 325–336.

[65] Y. Li, W. Wang, F. Yang, et al., “The Regulatory Roles of Neutrophils in Adaptive Immunity,” Cell Communication and Signaling 17 (2019): 147.

[66] M. Lad, A. S. Beniwal, and S. Jain, “Glioblastoma Induces the Recruitment and Differentiation of Dendritic-Like ‘Hybrid’ Neutrophils From Skull Bone Marrow,” Cancer Cell 42 (2024): 1549–1569.

[67] A. C. Mihaila, L. Ciortan, and R. D. Macarie, “Transcriptional Profiling and Functional Analysis of N1/N2 Neutrophils Reveal an Immunomodulatory Effect of S100A9-Blockade on the Pro-Inflammatory N1 Subpopulation,” Frontiers in immunology 12 (2021):708770.

[68] S. Huang, Y. Xie, and Z. Zhan, “Geranyl Hydroquinone Alleviates Rheumatoid Arthritis-Associated Pain by Suppressing Neutrophil Accumulation, N1 Polarization and ROS Production in Mice,” Redox Biology 82 (2025):103603.

[69] Y. Wang, J. Ma, and Y. Liu, “Unraveling the Complex Role of Tumor-Associated Neutrophils Within Solid Tumors,” Cancer Immunology, Immunotherapy 74 (2025): 210.

[70] S. B. Coffelt, M. D. Wellenstein, and K. E. de Visser, “Neutrophils in Cancer: Neutral No More,” Nature Reviews Cancer 16 (2016): 431–446.

[71] Z. G. Fridlender, J. Sun, and S. Kim, “Polarization of Tumor-Associated Neutrophil Phenotype by TGF-beta: ‘N1’ versus ‘N2’ TAN,” Cancer Cell 16 (2009): 183–194.

[72] A. C. Mihaila, L. Ciortan, and M. M. Tucureanu, “Anti-Inflammatory Neutrophils Reprogram Macrophages Toward a Pro-Healing Phenotype With Increased Efferocytosis Capacity,” Cells 13 (2024): 208.

[73] Y. Jiang, N. Wang, and J. Liu, “Intranasal Delivery of hMSC-Derived Supernatant for Treatment of Ischemic Stroke by Inhibiting the Pro-Inflammatory Polarization of Neutrophils,” Stem Cell Res Ther 16 (2025): 43.

[74] Z. Zhao, T. Liu, and Y. Liang, “N2-Polarized Neutrophils Reduce Inflammation in Rosacea by Regulating Vascular Factors and Proliferation of CD4⁺ T Cells,” Journal of Investigative Dermatology 142 (2022): 1835–1844.

[75] J. Y. Sagiv, J. Michaeli, and S. Assi, “Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer,” Cell reports 10 (2015): 562–573.

[76] I. Kwok, E. Becht, and Y. Xia, “Combinatorial Single-Cell Analyses of Granulocyte-Monocyte Progenitor Heterogeneity Reveals an Early Uni-Potent Neutrophil Progenitor,” Immunity 53 (2020): 303–318.

[77] B. L. Dumont, P. E. Neagoe, and E. Charles, “Low-Density Neutrophils and Neutrophil Extracellular Traps (NETs) Are New Inflammatory Players in Heart Failure,” Canadian Journal of Cardiology 40 (2024): 1524–1535.

[78] S. Henning, T. Reimers, and W. Abdulahad, “Low-Density Granulocytes and Neutrophil Extracellular Trap Formation Are Increased in Incomplete Systemic Lupus Erythematosus,” Rheumatology (Oxford) 64 (2025): 1234–1242.

[79] M. K. Thind, H. H. Uhlig, M. Glogauer, et al., “A Metabolic Perspective of the Neutrophil Life Cycle: New Avenues in Immunometabolism,” Frontiers in immunology 14 (2024):1334205.

[80] P. O. Leblanc, S. G. Bourgoin, P. E. Poubelle, et al., “Metabolic Regulation of Neutrophil Functions in Homeostasis and Diseases,” J Leukoc Biol 116 (2024): 456–468.

[81] M. C. Gomes, D. Brokatzky, M. K. Bielecka, et al., “Shigella Induces Epigenetic Reprogramming of Zebrafish Neutrophils,” Science Advances 9 (2023):eadf9706.

[82] A. de Juan, L. M. Ince, R. Pick, et al., “Artery-Associated Sympathetic Innervation Drives Rhythmic Vascular Inflammation of Arteries and Veins,” Circulation 140 (2019): 1100–1114.

[83] Y. Katayama, M. Battista, W. M. Kao, et al., “Signals From the Sympathetic Nervous System Regulate Hematopoietic Stem Cell Egress From Bone Marrow,” Cell 124 (2006): 407–421.

[84] S. Méndez-Ferrer, D. Lucas, M. Battista, and P. S. Frenette, “Haematopoietic Stem Cell Release Is Regulated by Circadian Oscillations,” Nature 452 (2008): 442–447.

[85] S. Méndez-Ferrer, M. Battista, and P. S. Frenette, “Cooperation of Beta (2)- and Beta (3)-adrenergic Receptors in Hematopoietic Progenitor Cell Mobilization,” Ann N Y Acad Sci 1192 (2010): 139–144.

[86] Y. Yuan, S. Wu, W. Li, and W. He, “A Tissue-Specific Rhythmic Recruitment Pattern of Leukocyte Subsets,” Frontiers in immunology 11 (2020): 102.

[87] M. J. Delano, K. M. Kelly-Scumpia, T. C. Thayer, et al., “Neutrophil Mobilization From the Bone Marrow During Polymicrobial Sepsis Is Dependent on CXCL12 Signaling,” Journal of Immunology 187(2011): 911–918.

[88] L. A. Cagle, A. L. Linderholm, L. M. Franzi, et al., “Early Mechanisms of Neutrophil Activation and Transmigration in Acute Lung Injury,” Front Physiol 13 (2022):1059686.

[89] E. P. Azevedo, N. C. Rochael, and A. B. Guimarães-Costa, “A Metabolic Shift Toward Pentose Phosphate Pathway Is Necessary for Amyloid Fibril- and Phorbol 12-Myristate 13-Acetate-Induced Neutrophil Extracellular Trap (NET) Formation,” Journal of Biological Chemistry 290 (2015): 22174–22183.

[90] L. G. Ng, J. B. Qin, and B. Roediger, “Visualizing the Neutrophil Response to Sterile Tissue Injury in Mouse Dermis Reveals a Three-Phase Cascade of Events,” Journal of Investigative Dermatology 131 (2011): 2058–2068.

[91] I. Ballesteros, A. Rubio-Ponce, and M. Genua, “Co-Option of Neutrophil Fates by Tissue Environments,” Cell 183 (2020): 1282–1297.

[92] M. Casanova-Acebes, J. A. Nicolás-Ávila, and J. L. Li, “Neutrophils Instruct Homeostatic and Pathological States in Naive Tissues,” Journal of Experimental Medicine 215 (2018): 2778–2795.

[93] I. Puga, M. Cols, and C. M. Barra, “B Cell-Helper Neutrophils Stimulate the Diversification and Production of Immunoglobulin in the Marginal Zone of the Spleen,” Nature Immunology 13 (2011): 170–180.

[94] C. Liao, S. Luo, and X. Liu, “Siglec-F⁺ Neutrophils in the Spleen Induce Immunosuppression Following Acute Infection,” Theranostics 14 (2024): 2589–2604.

[95] D. F. Gao, H. Peng, R. Gou, et al., “Exploring Neutrophil Extracellular Traps: Mechanisms of Immune Regulation and Future Therapeutic Potential,” Exp Hematol Oncol 14 (2025): 80.

[96] Q. Shu, N. Zhang, Y. Liu, et al., “IL-8 Triggers Neutrophil Extracellular Trap Formation Through an NADPH Oxidase- and Mitogen-Activated Protein Kinase-Dependent Mechanism in Uveitis,” Investigative Ophthalmology & Visual Science 64 (2023): 19.

[97] F. Neuenfeldt, J. C. Schumacher, R. Grieshaber-Bouyer, et al., “Inflammation Induces Pro-NETotic Neutrophils via TNFR2 Signaling,” Cell reports 39 (2022):110710.

[98] S. A. Oh, S. I. Seol, D. Davaanyam, et al., “Platelet-Derived HMGB1 Induces NETosis, Exacerbating Brain Damage in the Photothrombotic Stroke Model,” Molecular Medicine 31 (2025): 46.

[99] J. Zhao, N. Zhen, Q. Zhou, et al., “NETs Promote Inflammatory Injury by Activating cGAS-STING Pathway in Acute Lung Injury,” International Journal of Molecular Sciences 24 (2023): 5125.

[100] G. Sollberger, A. Choidas, G. L. Burn, et al., “Gasdermin D Plays a Vital Role in the Generation of Neutrophil Extracellular Traps,” Science Immunology 3 (2018):eaar6689.

[101] C. Blanco-Camarillo and C. Rosales, “Low-Density Neutrophils: Enigmatic Cells in Health and Disease,” Journal of Immunology Research 2025 (2025):3037744.

[102] J. Qu, J. Jin, M. Zhang, et al., “Neutrophil Diversity and Plasticity: Implications for Organ Transplantation,” Cell Mol Immunol 20 (2023): 993–1001.

[103] A. Asiri, J. Hazeldine, N. Moiemen, et al., “IL-8 Induces Neutrophil Extracellular Trap Formation in Severe Thermal Injury,” International Journal of Molecular Sciences 25 (2024): 7216.

[104] S. Jaboury, G. Helleberg, K. O'Shaughnessy, et al., “NETosis as an Oncologic Therapeutic Target: a Mini Review,” Frontiers in immunology 14 (2023):1170603.

[105] C. Gysemans, M. Beya, E. Pedace, et al., “Exploring Neutrophil Heterogeneity and Plasticity in Health and Disease,” Biomedicines 13 (2025): 597.

[106] C. Kaltenmeier, R. Yazdani, A. N. Morder, et al., “Neutrophil Extracellular Traps Promote T Cell Exhaustion in the Tumor Microenvironment,” Frontiers in immunology 12 (2021):785222.

[107] H. Kajioka, K. Takasaki, K. Morimoto-Kitamura, et al., “Targeting Neutrophil Extracellular Traps With Thrombomodulin Prevents Pancreatic Cancer Metastasis,” Cancer Letters 497 (2021): 1–13.

[108] O. Rodríguez-Espinosa, O. Rojas-Espinosa, M. M. Moreno-Altamirano, et al., “Metabolic Requirements for Neutrophil Extracellular Traps Formation,” Immunology 145 (2015): 213–224.

[109] P. Amini, D. Stojkov, A. Felser, et al., “Neutrophil Extracellular Trap Formation Requires OPA1-Dependent Glycolytic ATP Production,” Nature Communications 9 (2018): 2958.

[110] D. Awasthi, S. Nagarkoti, S. Sadaf, et al., “Glycolysis Dependent Lactate Formation in Neutrophils: a Metabolic Link Between NOX-Dependent and Independent NETosis,” Biochim Biophys Acta Mol Basis Dis 1865 (2019):165542.

[111] A. Tambralli, A. Harbaugh, S. K. NaveenKumar, et al., “Neutrophil Glucose Flux as a Therapeutic Target in Antiphospholipid Syndrome,” Journal of Clinical Investigation 134 (2024): e169893.

[112] D. Awasthi, S. Nagarkoti, S. Sadaf, et al., “Modulations in Human Neutrophil Metabolome and S-Glutathionylation of Glycolytic Pathway Enzymes During the Course of Extracellular Trap Formation,” Biochim Biophys Acta Mol Basis Dis 1869 (2023):166581.

[113] Y. Xia, J. Lan, J. Yang, et al., “Saturated Fatty Acid-Induced Neutrophil Extracellular Traps Contribute to Exacerbation and Biologic Therapy Resistance in Obesity-Related Psoriasis,” Cell Mol Immunol 22 (2025): 597–611.

[114] K. E. M. Hellenthal, K. Thomas, N. Ludwig, et al., “Glutamine Modulates Neutrophil Recruitment and Effector Functions During Sterile Inflammation,” J Leukoc Biol 117 (2025):qiae243.

[115] M. A. Sanchez-Garcia, P. Sadiku, B. M. Ortmann, et al., “Hypoxia Induces Histone Clipping and H3K4me3 Loss in Neutrophil Progenitors Resulting in Long-Term Impairment of Neutrophil Immunity,” Nature Immunology 26 (2025): 1903–1915.

[116] S. Saeed, J. Quintin, H. H. Kerstens, et al., “Epigenetic Programming of Monocyte-to-Macrophage Differentiation and Trained Innate Immunity,” Science 345 (2014):1251086.

[117] S. Fanucchi, J. Domínguez-Andrés, L. A. B. Joosten, et al., “The Intersection of Epigenetics and Metabolism in Trained Immunity,” Immunity 54 (2021): 32–43.

[118] N. Tamassia, F. Bianchetto-Aguilera, S. Gasperini, et al., “Induction of OCT2 Contributes to Regulate the Gene Expression Program in Human Neutrophils Activated via TLR8,” Cell reports 3 (2021):109143.

[119] P. Piatek, M. Namiecinska, N. Lewkowicz, et al., “Changes Within H3K4me3-Marked Histone Reveal Molecular Background of Neutrophil Functional Plasticity,” Frontiers in immunology 13 (2022):906311.

[120] H. J. Hamam, M. A. Khan, and N. Palaniyar, “Histone Acetylation Promotes Neutrophil Extracellular Trap Formation,” Biomolecules 9 (2019): 32.

[121] V. Poli, V. Pui-Yan Ma, M. Di Gioia, et al., “Zinc-Dependent Histone Deacetylases Drive Neutrophil Extracellular Trap Formation and Potentiate Local and Systemic Inflammation,” Iscience 24 (2021):103256.

[122] H. D. Lewis, J. Liddle, J. E. Coote, et al., “Inhibition of PAD4 Activity Is Sufficient to Disrupt Mouse and Human NET Formation,” Nature Chemical Biology 11 (2015): 189–191.

[123] A. Hawez, D. Taha, A. Algaber, et al., “MiR-155 Regulates Neutrophil Extracellular Trap Formation and Lung Injury in Abdominal Sepsis,” J Leukoc Biol 111 (2022): 391–400.

[124] T. L. Liao, C. C. Lin, Y. H. Chen, et al., “Reduced miR-223 Increases Blood Neutrophil Extracellular Trap and Promotes Skin Inflammation in Atopic Dermatitis,” Allergy 78 (2023): 3252–3254.

[125] J. Ma, Y. Zhang, J. Li, et al., “Regulation of Histone H3K27 Methylation in Inflammation and Cancer,” Mol Biomed 6 (2025): 14.

[126] D. Azzouz, M. A. Khan, and N. Palaniyar, “ROS Induces NETosis by Oxidizing DNA and Initiating DNA Repair,” Cell Death Discov 7 (2021): 113.

[127] D. Azzouz and N. Palaniyar, “ROS and DNA Repair in Spontaneous versus Agonist-Induced NETosis: Context Matters,” Frontiers in immunology 13 (2022):1033815.

[128] K. D. Metzler, C. Goosmann, A. Lubojemska, et al., “A Myeloperoxidase-Containing Complex Regulates Neutrophil Elastase Release and Actin Dynamics During NETosis,” Cell reports 8 (2014): 883–896.

[129] H. Björnsdottir, A. Welin, E. Michaëlsson, et al., “Neutrophil NET Formation Is Regulated From the Inside by Myeloperoxidase-Processed Reactive Oxygen Species,” Free Radic Biol Med 89 (2015): 1024–1035.

[130] Y. Sang, H. Liu, B. Li, et al., “Analysis of GSDMD-N Abnormality Promoting Neutrophil NETs Mediated RA Disease Through NLRP3-Dependent Pathway,” Frontiers in immunology 16 (2025):1652608.

[131] K. W. Chen, M. Monteleone, D. Boucher, et al., “Noncanonical Inflammasome Signaling Elicits Gasdermin D-Dependent Neutrophil Extracellular Traps,” Science Immunology 3 (2018):eaar6676.

[132] F. Apel, L. Andreeva, L. S. Knackstedt, et al., “The Cytosolic DNA Sensor cGAS Recognizes Neutrophil Extracellular Traps,” Science signaling 14 (2021):eaax7942.

[133] C. Farrera and B. Fadeel, “Macrophage Clearance of Neutrophil Extracellular Traps Is a Silent Process,” Journal of Immunology 191 (2013): 2647–2656.

[134] S. Ovadia, A. Özcan, and A. Hidalgo, “The Circadian Neutrophil, Inside-Out,” J Leukoc Biol 113 (2023): 555–566.

[135] J. M. Adrover, C. Del Fresno, G. Crainiciuc, et al., “A Neutrophil Timer Coordinates Immune Defense and Vascular Protection,” Immunity 50 (2019): 390–402.

[136] T. Zeng, L. Liang, W. Deng, et al., “BMAL1 Plays a Crucial Role in Immune Homeostasis During Sepsis-Induced Acute Lung Injury,” Biochemical Pharmacology 226 (2024):116379.

[137] A. N. Rankin, S. V. Hendrix, and S. K. Naik, “Exploring the Role of Low-Density Neutrophils During Mycobacterium Tuberculosis Infection,” Frontiers in Cellular and Infection Microbiology 12 (2022):901590.

[138] C. N. Muefong and J. S. Sutherland, “Neutrophils in Tuberculosis-Associated Inflammation and Lung Pathology,” Frontiers in immunology 11 (2020): 962.

[139] J. T. Andrews, Z. Zhang, and G. V. R. K. Prasad, “Metabolically Active Neutrophils Represent a Permissive Niche for Mycobacterium Tuberculosis,” Mucosal Immunol 17 (2024): 825–842.

[140] F. Venet and G. Monneret, “Advances in the Understanding and Treatment of Sepsis-Induced Immunosuppression,” Nature Reviews Nephrology 14 (2018): 121–137.

[141] Y. Liu, R. Song, and Z. Lu, “The RNA M⁶A Demethylase ALKBH5 Drives Emergency Granulopoiesis and Neutrophil Mobilization by Upregulating G-CSFR Expression,” Cell Mol Immunol 21 (2024): 6–18.

[142] J. Lu, J. Liu, and A. Li, “Roles of Neutrophil Reactive Oxygen Species (ROS) Generation in Organ Function Impairment in Sepsis,” J Zhejiang Univ Sci B 23 (2022): 437–450.

[143] B. J. Fisher, I. M. Seropian, and D. Kraskauskas, “Ascorbic Acid Attenuates Lipopolysaccharide-Induced Acute Lung Injury,” Critical Care Medicine 39 (2011): 1454–1460.

[144] Y. Jiao, W. Li, and W. Wang, “Platelet-Derived Exosomes Promote Neutrophil Extracellular Trap Formation During Septic Shock,” Critical Care 24 (2020): 380.

[145] X. Qi, Y. Yu, and R. Sun, “Identification and Characterization of Neutrophil Heterogeneity in Sepsis,” Critical Care 25 (2021): 50.

[146] L. Fang, Y. Song, and J. Chen, “The Dual Role of Neutrophils in Sepsis-Associated Liver Injury,” Frontiers in immunology 16 (2025):1538282.

[147] K. Moriyama and O. Nishida, “Targeting Cytokines, Pathogen-Associated Molecular Patterns, and Damage-Associated Molecular Patterns in Sepsis via Blood Purification,” International Journal of Molecular Sciences 22 (2021): 8882.

[148] C. Ma, K. Liu, and F. Wang, “Neutrophil Membrane-Engineered Panax Ginseng Root-Derived Exosomes Loaded miRNA 182–5p Targets NOX4/Drp-1/NLRP3 Signal Pathway to Alleviate Acute Lung Injury in Sepsis: Experimental Studies,” Int J Surg 110 (2024): 72–86.

[149] Y. Jiang, B. R. Rosborough, and J. Chen, “Single Cell RNA Sequencing Identifies an Early Monocyte Gene Signature in Acute Respiratory Distress Syndrome,” JCI Insight 5 (2020):e135678.

[150] K. E. Traber, E. L. Dimbo, and A. T. Shenoy, “Neutrophil-Derived Oncostatin M Triggers Diverse Signaling Pathways During Pneumonia,” Infection and Immunity 89 (2021): e00655–20.

[151] P. E. Gray and C. David, “Inborn Errors of Immunity and Autoimmune Disease,” J Allergy Clin Immunol Pract 11 (2023): 1602–1622.

[152] S. Nakabo, J. Romo-Tena, and M. J. Kaplan, “Neutrophils as Drivers of Immune Dysregulation in Autoimmune Diseases With Skin Manifestations,” Journal of Investigative Dermatology 142 (2022): 823–833.

[153] H. Wang, S. J. Kim, and Y. Lei, “Neutrophil Extracellular Traps in Homeostasis and Disease,” Signal Transduct Target Ther 9 (2024): 235.

[154] G. Wigerblad and M. J. Kaplan, “Neutrophil Extracellular Traps in Systemic Autoimmune and Autoinflammatory Diseases,” Nature Reviews Immunology 23 (2023): 274–288.

[155] H. Ye, Q. Yang, H. Guo, et al., “Internalisation of Neutrophils Extracellular Traps by Macrophages Aggravate Rheumatoid Arthritis via Rab5a,” RMD Open 10 (2024):e003847.

[156] C. Soni and B. Reizis, “Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects,” Frontiers in immunology 10 (2019): 1601.

[157] E. Villanueva, S. Yalavarthi, and C. C. Berthier, “Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus,” Journal of Immunology 187 (2011): 538–552.

[158] J. M. Kahlenberg, C. Carmona-Rivera, and C. K. Smith, “Neutrophil Extracellular Trap-Associated Protein Activation of the NLRP3 Inflammasome Is Enhanced in Lupus Macrophages,” Journal of Immunology 190 (2013): 1217–1226.

[159] M. F. Denny, S. Yalavarthi, and W. Zhao, “A Distinct Subset of Proinflammatory Neutrophils Isolated From Patients With Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNs,” Journal of Immunology 184 (2010): 3284–3297.

[160] C. Carmona-Rivera and M. J. Kaplan, “Low-Density Granulocytes: a Distinct Class of Neutrophils in Systemic Autoimmunity,” Seminars in immunopathology 35 (2013): 455–463.

[161] S. H. Tay, T. Celhar T, and A. M. Fairhurst, “Low-Density Neutrophils in Systemic Lupus Erythematosus,” Arthritis Rheumatol 72 (2020): 1587–1595.

[162] H. Xu, M. Zhan, and Z. Wu, “Aberrant Expansion of CD177⁺ Neutrophils Promotes Endothelial Dysfunction in Systemic Lupus Erythematosus via Neutrophil Extracellular Traps,” Journal of Autoimmunity 152 (2025):103399.

[163] R. Lande, D. Ganguly, and V. Facchinetti, “Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus,” Science Translational Medicine 3 (2011):73ra19.

[164] A. Hakkim, B. G. Fürnrohr, and K. Amann, “Impairment of Neutrophil Extracellular Trap Degradation Is Associated With Lupus Nephritis,” Proceedings National Academy of Science USA 107 (2010): 9813–9818.

[165] C. Lood, L. P. Blanco, and M. M. Purmalek, “Neutrophil Extracellular Traps Enriched in Oxidized Mitochondrial DNA Are Interferogenic and Contribute to Lupus-Like Disease,” Nature Medicine 22 (2016): 146–153.

[166] B. Frade-Sosa and R. Sanmartí, “Neutrophils, Neutrophil Extracellular Traps, and Rheumatoid Arthritis: an Updated Review for Clinicians,” Reumatol Clin (Engl Ed) 19 (2023): 515–526.

[167] R. Khandpur, C. Carmona-Rivera, and A. Vivekanandan-Giri, “NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis,” Science Translational Medicine 5 (2013):178ra40.

[168] R. G. S. Chirivi, J. W. G. van Rosmalen, and M. van der Linden, “Therapeutic ACPA Inhibits NET Formation: a Potential Therapy for Neutrophil-Mediated Inflammatory Diseases,” Cell Mol Immunol 18 (2021): 1528–1544.

[169] K. A. Lloyd, G. Wigerblad, and P. Sahlström, “Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis,” Frontiers in immunology 9 (2019): 3033.

[170] E. Zhou, J. Wu, and X. Zhou, “The Neutrophil-Lymphocyte Ratio Predicts all-Cause and Cardiovascular Mortality Among U.S. Adults With Rheumatoid Arthritis: Results From NHANES 1999–2020,” Frontiers in immunology 14 (2023):1309835.

[171] G. L. Erre, P. Paliogiannis, and F. Castagna, “Meta-Analysis of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio in Rheumatoid Arthritis,” European Journal of Clinical Investigation 49 (2019):e13037.

[172] W. Ding, R. La, and S. Wang, “Associations Between Neutrophil Percentage to Albumin Ratio and Rheumatoid Arthritis versus Osteoarthritis: a Comprehensive Analysis Utilizing the NHANES Database,” Frontiers in immunology 16 (2025):1436311.

[173] D. C. Hinshaw and L. A. Shevde, “The Tumor Microenvironment Innately Modulates Cancer Progression,” Cancer Research 79 (2019): 4557–4566.

[174] X. Huang, E. Nepovimova, and V. Adam, “Neutrophils in Cancer Immunotherapy: Friends or Foes?” Molecular cancer 23 (2024): 107.

[175] S. Yang, B. Sun, and J. Li, “Neutrophil Extracellular Traps Promote Angiogenesis in Gastric Cancer,” Cell Communication and Signaling 21 (2023): 176.

[176] T. Luckett, M. Abudula, and L. Ireland, “Mesothelin Secretion by Pancreatic Cancer Cells Co-Opts Macrophages and Promotes Metastasis,” Cancer Research 84 (2024): 527–544.

[177] W. Jing, G. Wang, and Z. Cui, “Tumor-Neutrophil Cross Talk Orchestrates the Tumor Microenvironment to Determine the Bladder Cancer Progression,” Proceedings National Academy of Science USA 121 (2024):e2312855121.

[178] N. Glodde, T. Bald, and D. van den Boorn-Konijnenberg, “Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy,” Immunity 47 (2017): 789–802.

[179] C. E. de Andrea, M. C. Ochoa, and M. Villalba-Esparza, “Heterogenous Presence of Neutrophil Extracellular Traps in Human Solid Tumours Is Partially Dependent on IL-8,” Journal of Pathology 255 (2021): 190–201.

[180] F. Favaro, F. Luciano-Mateo, and J. Moreno-Caceres, “TRAIL Receptors Promote Constitutive and Inducible IL-8 Secretion in Non-Small Cell Lung Carcinoma,” Cell death & disease 13 (2022): 1046.

[181] S. Jaillon, A. Ponzetta, and D. Di Mitri, “Neutrophil Diversity and Plasticity in Tumour Progression and Therapy,” Nature Reviews Cancer 20 (2020): 485–503.

[182] S. Carnevale, S. Ghasemi, and A. Rigatelli, “The Complexity of Neutrophils in Health and Disease: Focus on Cancer,” Seminars in Immunology 48 (2020):101409.

[183] S. Patel, S. Fu, and J. Mastio, “Unique Pattern of Neutrophil Migration and Function During Tumor Progression,” Nature Immunology 19 (2018): 1236–1247.

[184] L. Yang, Q. Liu, and X. Zhang, “DNA of Neutrophil Extracellular Traps Promotes Cancer Metastasis via CCDC25,” Nature 583 (2020): 133–138.

[185] R. Liu, E. Zhao, and F. Wang, “CCDC25: Precise Navigator for Neutrophil Extracellular Traps on the Prometastatic Road,” Signal Transduct Target Ther 5 (2020): 162.

[186] C. Zhu, C. Li, and Y. Du, “Precise Oligopeptides Block CCDC25 Interaction With DNA in Neutrophil Extracellular Traps Inhibiting Tumor Metastasis,” ACS Appl Mater Interfaces 17 (2025): 15208–15219.

[187] H. L. Matlung, L. Babes, and X. W. Zhao, “Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis,” Cell reports 23 (2018): 3946–3959.

[188] S. K. Nikkhoi, G. Li, and S. Eleya, “Bispecific Killer Cell Engager With High Affinity and Specificity Toward CD16a on NK Cells for Cancer Immunotherapy,” Frontiers in immunology 13 (2023):1039969.

[189] H. Luo, N. Ikenaga, and K. Nakata, “Tumor-Associated Neutrophils Upregulate Nectin2 Expression, Creating the Immunosuppressive Microenvironment in Pancreatic Ductal Adenocarcinoma,” Journal of Experimental & Clinical Cancer Research 43 (2024): 258.

[190] S. Y. Chen, H. C. Kung, and B. Espinoza, “Targeting Heterogeneous Tumor Microenvironments in Pancreatic Cancer Mouse Models of Metastasis by TGF-β Depletion,” JCI Insight 9 (2024):e182766.

[191] Y. Zhang, V. Chandra, and E. R. Sanchez, “Interleukin-17-Induced Neutrophil Extracellular Traps Mediate Resistance to Checkpoint Blockade in Pancreatic Cancer,” Journal of Experimental Medicine 217 (2020):e20190354.

[192] B. Schoeps, C. Eckfeld, and O. Prokopchuk, “TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer,” Cancer Research 81 (2021): 3568–3579.

[193] Y. Xiao, M. Cong, and J. Li, “Cathepsin C Promotes Breast Cancer Lung Metastasis by Modulating Neutrophil Infiltration and Neutrophil Extracellular Trap Formation,” Cancer Cell 39 (2021): 423–437.

[194] J. Park, R. W. Wysocki, and Z. Amoozgar, “Cancer Cells Induce Metastasis-Supporting Neutrophil Extracellular DNA Traps,” Science Translational Medicine 8 (2016):361ra138.

[195] S. Yan, W. Zhao, and J. Du, “C-FOS Promotes the Formation of Neutrophil Extracellular Traps and the Recruitment of Neutrophils in Lung Metastasis of Triple-Negative Breast Cancer,” Journal of Experimental & Clinical Cancer Research 44 (2025): 108.

[196] X. Zhou, C. Wu, and X. Wang, “Tumor Cell-Released Autophagosomes (TRAPs) Induce PD-L1-Decorated NETs That Suppress T-Cell Function to Promote Breast Cancer Pulmonary Metastasis,” Journal for ImmunoTherapy of Cancer 12 (2024):e009082.

[197] P. Li, M. Lu, and J. Shi, “Lung Mesenchymal Cells Elicit Lipid Storage in Neutrophils That Fuel Breast Cancer Lung Metastasis,” Nature Immunology 21 (2020): 1444–1455.

[198] Y. Zhao, Z. Liu, and G. Liu, “Neutrophils Resist Ferroptosis and Promote Breast Cancer Metastasis Through Aconitate Decarboxylase 1,” Cell metabolism 35 (2023): 1688–1703.

[199] M. Qi, Y. Xia, and Y. Wu, “Lin28B-High Breast Cancer Cells Promote Immune Suppression in the Lung Pre-Metastatic Niche via Exosomes and Support Cancer Progression,” Nature Communications 13 (2022): 897.

[200] D. Chu, X. Dong, and X. Shi, “Neutrophil-Based Drug Delivery Systems,” Advanced Materials 30 (2018):e1706245.

[201] Y. Han, R. Zhao, and F. Xu, “Neutrophil-Based Delivery Systems for Nanotherapeutics,” Small 14 (2018):e1801674.

[202] Y. Liu, Y. Yu, and M. Wang, “Recent Progress in Therapeutic Strategies and Biomimetic Nanomedicines Based on Neutrophils for Inflammation Treatment,” Nanomedicine (Lond) 18 (2023): 485–500.

[203] M. A. Subhan and V. P. Torchilin, “Neutrophils as an Emerging Therapeutic Target and Tool for Cancer Therapy,” Life Sciences 285 (2021):119952.

[204] J. Xue, Z. Zhao, and L. Zhang, “Neutrophil-Mediated Anticancer Drug Delivery for Suppression of Postoperative Malignant Glioma Recurrence,” Nature Nanotechnology 12 (2017): 692–700.

[205] Y. Li, X. Teng, and Y. Wang, “Neutrophil Delivered Hollow Titania Covered Persistent Luminescent Nanosensitizer for Ultrosound Augmented Chemo/Immuno Glioblastoma Therapy,” Adv Sci (Weinh) 8 (2021):e2004381.

[206] Z. Luo, Y. Lu, and Y. Shi, “Neutrophil Hitchhiking for Drug Delivery to the Bone Marrow,” Nature Nanotechnology 18 (2023): 647–656.

[207] N. Yang, M. Li, and L. Wu, “Peptide-Anchored Neutrophil Membrane-Coated Biomimetic Nanodrug for Targeted Treatment of Rheumatoid Arthritis,” J Nanobiotechnology 21 (2023): 13.

[208] I. L. Linde, T. R. Prestwood, and J. Qiu, “Neutrophil-Activating Therapy for the Treatment of Cancer,” Cancer Cell 41 (2023): 356–372.

[209] C. Wang, X. Zheng, and J. Zhang, “CD300ld on Neutrophils Is Required for Tumour-Driven Immune Suppression,” Nature 621 (2023): 830–839.

[210] K. Kingwell, “Neutrophil-Targeting Drug Seeks First Approval in an Inflammatory Lung Disease,” Nat Rev Drug Discovery 24 (2025): 487–489.

[211] L. Ottonello, A. L. Epstein, and P. Dapino, “Monoclonal Lym-1 Antibody-Dependent Cytolysis by Neutrophils Exposed to Granulocyte-Macrophage Colony-Stimulating Factor: Intervention of FcgammaRII (CD32), CD11b-CD18 Integrins, and CD66b Glycoproteins,” Blood 93 (1999): 3505–3511.

[212] C. S. Lin, J. G. Wann, C. W. Hsiao, et al., “Intracellular Acidification Enhances Neutrophil Phagocytosis in Chronic Haemodialysis Patients: Possible Role of CD11b/CD18,” Nephrology, Dialysis, Transplantation 23(2008): 1642–1649.

[213] A. Mócsai, B. Walzog, and C. A. Lowell, “Intracellular Signalling During Neutrophil Recruitment,” Cardiovascular Research 107 (2015): 373–385.

[214] M. van der Linden, S. Kumari, and D. Montizaan, “Anti-Citrullinated Histone Monoclonal Antibody CIT-013, a Dual Action Therapeutic for Neutrophil Extracellular Trap-Associated Autoimmune Diseases,” MAbs 15 (2023):2281763.

[215] G. Boivin, J. Faget, and P. B. Ancey, “Durable and Controlled Depletion of Neutrophils in Mice,” Nature Communications 11 (2020): 2762.

[216] M. T. Masucci, M. Minopoli, and S. Del Vecchio, “The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis,” Frontiers in immunology 11 (2020): 1749.

[217] Y. Liu, Y. Qu, and C. Liu, “Neutrophil Extracellular Traps: Potential Targets for the Treatment of Rheumatoid Arthritis With Traditional Chinese Medicine and Natural Products,” Phytotherapy Research 38 (2024): 5067–5087.

[218] J. Ye, Y. Qin, and H. Liu, “Inhibiting Neutrophil Extracellular Trap Formation Through Iron Regulation for Enhanced Cancer Immunotherapy,” ACS Nano 19 (2025): 9167–9181.

[219] L. Del Giacco and C. Cattaneo, “Introduction to Genomics,” Methods Mol Bio 823 (2012): 79–88.

[220] M. Nasri, M. U. Ritter, and P. Mir, “CRISPR-Cas9n-Mediated ELANE Promoter Editing for Gene Therapy of Severe Congenital Neutropenia,” Molecular Therapy 32 (2024): 1628–1642.

[221] Z. Shu, M. Deng, and T. Han, “De Novo Deep Intron ELANE Mutation Resulting in Severe Congenital Neutropenia,” Journal of Clinical Immunology 44 (2024): 183.

[222] T. Tidwell, J. Wechsler, and R. C. Nayak, “Neutropenia-Associated ELANE Mutations Disrupting Translation Initiation Produce Novel Neutrophil Elastase Isoforms,” Blood 123 (2014): 562–569.

[223] N. T. Tran, R. Graf, and A. Wulf-Goldenberg, “CRISPR-Cas9-Mediated ELANE Mutation Correction in Hematopoietic Stem and Progenitor Cells to Treat Severe Congenital Neutropenia,” Molecular Therapy 28 (2020): 2621–2634.

[224] C. Klein, “Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1),” Journal of Clinical Immunology 37 (2017): 117–122.

[225] C. Klein, M. Grudzien, and G. Appaswamy, “HAX1 Deficiency Causes Autosomal Recessive Severe Congenital Neutropenia (Kostmann Disease),” Nature Genetics 39 (2007): 86–92.

[226] R. E. Person, F. Q. Li, and Z. Duan, “Mutations in Proto-Oncogene GFI1 Cause Human Neutropenia and Target ELA2,” Nature Genetics 34 (2003): 308–312.

[227] D. E. Muench, A. Olsson, and K. Ferchen, “Mouse Models of Neutropenia Reveal Progenitor-Stage-Specific Defects,” Nature 582 (2020): 109–114.

[228] Z. Wang, M. Gerstein, and M. Snyder, “RNA-Seq: a Revolutionary Tool for Transcriptomics,” Nature Reviews Genetics 10 (2009): 57–63.

[229] T. L. S. A. Rosa, T. Leal-Calvo, and I. F. Tavares, “Whole Blood Transcriptomics Reveals the Enrichment of Neutrophil Activation Pathways During Erythema Nodosum Leprosum Reaction,” Frontiers in immunology 15 (2024):1366125.

[230] B. Chen, H. Fan, and X. Pang, “Single-Cell and Spatial Transcriptomics Reveals an Anti-Tumor Neutrophil Subgroup in Microwave Thermochemotherapy-Treated Lip Cancer,” Int J Oral Sci 17 (2025): 40.

[231] S. Hanash, “Disease Proteomics,” Nature 422 (2003): 226–232.

[232] E. A. Chapman, M. Lyon, and D. Simpson, “Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus,” Frontiers in immunology 10 (2019): 423.

[233] E. R. Reed, K. B. Chandler, and P. Lopez, “Cross-Platform Proteomics Signatures of Extreme Old Age,” Geroscience 47 (2025): 1199–1220.

[234] A. Fava, D. A. Rao, and C. Mohan, “Urine Proteomics and Renal Single-Cell Transcriptomics Implicate Interleukin-16 in Lupus Nephritis,” Arthritis Rheumatol 74 (2022): 829–839.

[235] A. Fava, J. Buyon, and L. Magder, “Urine Proteomic Signatures of Histological Class, Activity, Chronicity, and Treatment Response in Lupus Nephritis,” JCI Insight 9 (2024):e172569.

[236] H. Kreimeyer, C. G. Gonzalez, and M. F. Fondevila, “Faecal Proteomics Links Neutrophil Degranulation With Mortality in Patients With Alcohol-Associated Hepatitis,” Gut 74 (2024): 103–115.

[237] Y. P. Zhu, L. Padgett, and H. Q. Dinh, “Identification of an Early Unipotent Neutrophil Progenitor With Pro-tumoral Activity in Mouse and Human Bone Marrow,” Cell reports 24 (2018): 2329–2341.

[238] H. W. Jackson, J. R. Fischer, and V. R. T. Zanotelli, “The Single-Cell Pathology Landscape of Breast Cancer,” Nature 578 (2020): 615–620.

[239] A. F. Rendeiro, H. Ravichandran, and Y. Bram, “The Spatial Landscape of Lung Pathology During COVID-19 Progression,” Nature 593 (2021): 564–569.

[240] M. Guilliams, J. Bonnardel, and B. Haest, “Spatial Proteogenomics Reveals Distinct and Evolutionarily Conserved Hepatic Macrophage Niches,” Cell 185 (2022): 379–396.

[241] M. E. Shaul, L. Levy, and J. Sun, “Tumor-Associated Neutrophils Display a Distinct N1 Profile Following TGFβ Modulation: a Transcriptomics Analysis of Pro- vs. Antitumor TANs,” Oncoimmunology 5 (2016):e1232221.

[242] T. R. Haage, E. Charakopoulos, V. Bhuria, et al., “Neutrophil-Specific Expression of JAK2-V617F or CALRmut Induces Distinct Inflammatory Profiles in Myeloproliferative Neoplasia,” Journal of hematology & oncology 17(2024): 43.

[243] M. De Borre, H. Che, and Q. Yu, “Cell-free DNA Methylome Analysis for Early Preeclampsia Prediction,” Nature Medicine 29 (2023): 2206–2215.

[244] I. Mishalian, R. Bayuh, and L. Levy, “Tumor-Associated Neutrophils (TAN) Develop Pro-Tumorigenic Properties During Tumor Progression,” Cancer Immunology, Immunotherapy 62 (2013): 1745–1756.

[245] V. Finisguerra, G. Di Conza, and M. Di Matteo, “MET Is Required for the Recruitment of Anti-Tumoural Neutrophils,” Nature 522 (2015): 349–353.

[246] J. Schulte-Schrepping, N. Reusch N, and D. Paclik, “Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment,” Cell 182 (2020): 1419–1440.

[247] W. Sun, R. Wang, and S. Ouyang, “‘Weibing’ in Traditional Chinese Medicine-Biological Basis and Mathematical Representation of Disease-Susceptible State,” Acta Pharm Sin B 15 (2025): 2363–2371.

[248] Y. Wu, J. Ma, and X. Yang, “Neutrophil Profiling Illuminates Anti-Tumor Antigen-Presenting Potency,” Cell 187 (2024): 1422–1439.

[249] M. Metzemaekers, M. Gouwy, and P. Proost, “Neutrophil Chemoattractant Receptors in Health and Disease: Double-Edged Swords,” Cell Mol Immunol 17 (2020): 433–450.

[250] G. S. Gullotta, D. De Feo, E. Friebel, et al., “Age-induced Alterations of Granulopoiesis Generate Atypical Neutrophils That Aggravate Stroke Pathology,” Nature Immunology 24 (2023): 925–940.

[251] C. W. Tseng and G. Y. Liu, “Expanding Roles of Neutrophils in Aging Hosts,” Current Opinion in Immunology 29 (2014): 43–48.

[252] M. E. Brunck, S. B. Andersen, and N. E. Timmins, “Absolute Counting of Neutrophils in Whole Blood Using Flow Cytometry,” Cytometry Part A: the journal of the International Society for Analytical Cytology 85 (2014): 1057–1064.

[253] J. He, Z. Lin, and C. Song, “High Absolute Neutrophil Count With Type 2 Diabetes Is Associated With Adverse Outcome in Patients With Coronary Artery Disease: a Large-scale Cohort Study,” Front Endocrinol (Lausanne) 14 (2023):1129633.

[254] M. Yang, J. Liu, and J. Xu, “Elevated Systemic Neutrophil Count Is Associated With Diabetic Macroalbuminuria Among Elderly Chinese,” Int J Endocrinol 2015 (2015):348757.

[255] K. M. Rigby and F. R. DeLeo, “Neutrophils in Innate Host Defense Against Staphylococcus Aureus Infections,” Seminars in immunopathology 34 (2012): 237–259.

[256] C. Ledderose, E. A. Valsami, and M. Elevado, “Adenosine Triphosphate Release From Influenza-Infected Lungs Enhances Neutrophil Activation and Promotes Disease Progression,” Journal of Infectious Diseases 230 (2024): 120–130.

[257] C. F. Urban and J. E. Nett, “Neutrophil Extracellular Traps in Fungal Infection,” Seminars in cell & developmental biology 89 (2019): 47–57.

[258] S. de Oliveira, E. E. Rosowski, and A. Huttenlocher, “Neutrophil Migration in Infection and Wound Repair: Going Forward in Reverse,” Nature Reviews Immunology 16 (2016): 378–391.

[259] D. Boff, H. Crijns, and M. M. Teixeira, “Neutrophils: Beneficial and Harmful Cells in Septic Arthritis,” International Journal of Molecular Sciences 19 (2018): 468.

[260] B. W. Bardoel, E. F. Kenny, and G. Sollberger, “The Balancing Act of Neutrophils,” Cell Host & Microbe 15 (2014): 526–536.

[261] E. Mortaz, S. D. Alipoor, and I. M. Adcock, “Update on Neutrophil Function in Severe Inflammation,” Frontiers in immunology 9 (2018): 2171.

[262] S. Diem, S. Schmid, and M. Krapf, “Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Nivolumab,” Lung Cancer 111 (2017): 176–181.

[263] Y. He, X. Liu, and M. Wang, “Neutrophil-to-Lymphocyte Ratio as a Predictor of Cardiovascular Mortality in Cancer Survivors,” Scientific Reports 14 (2024):20980.

[264] J. Yu, L. Huang, and T. Dong, “Prediction of Outcomes After Chemoradiotherapy for Cervical Cancer by Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio,” Journal of Obstetrics and Gynaecology 44 (2024):2361858.

[265] F. Mollinedo, “Neutrophil Degranulation, Plasticity, and Cancer Metastasis,” Trends in Immunology 40 (2019): 228–242.

[266] M. A. Cupp, M. Cariolou, and I. Tzoulaki, “Neutrophil to Lymphocyte Ratio and Cancer Prognosis: an Umbrella Review of Systematic Reviews and Meta-Analyses of Observational Studies,” BMC Medicine [Electronic Resource] 18 (2020): 360.

[267] P. S. L. Schäfer, D. Dimitrov, E. J. Villablanca, and J. Saez-Rodriguez, “Integrating Single-Cell Multi-Omics and Prior Biological Knowledge for a Functional Characterization of the Immune System.” Nature Immunology 25(2024): 405–417.

[268] S. Zou, Q. Chen, Z. Shen, et al., “Update on the Roles of Regular Daily Rhythms in Combating Brain Tumors,” European Journal of Pharmacology 986 (2025):177144.

[269] M. Ersoy, “Optimizing Nivolumab Efficacy: the Role of Dosing Time in Advanced Non-Small Cell Lung Cancer,” Medical Science Monitor 31 (2025):e950963.

[270] P. F. Innominato, T. Landré, A. Karaboué, et al., “Timing of Immunotherapy in Practice: Feasibility and Impact of Morning Checkpoint Inhibitor Administration,” JCO Oncol Pract (2025) Published online December 15.

RIGHTS & PERMISSIONS

2026 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.